1 | previous | 20,890 |
2 | molecular-genetic | 5 |
3 | postrehabilitation | 5 |
4 | iscomatrix™ | 3 |
5 | pervious | 3 |
6 | cochrane-style | 2 |
7 | gh-deficiency | 2 |
8 | meta-analyses.this | 2 |
9 | part-time/full-time | 2 |
10 | stage-adapted | 2 |
11 | stress-trained | 2 |
12 | tj- | 2 |
13 | two-to-five | 2 |
14 | 13,498 | 1 |
15 | 13,502 | 1 |
16 | 147,774 | 1 |
17 | 294,159 | 1 |
18 | 5,503 | 1 |
19 | 5/672 | 1 |
20 | arm-training | 1 |
21 | bioinformatic-driven | 1 |
22 | ckd.eight | 1 |
23 | ckd.three | 1 |
24 | electrifying | 1 |
25 | electroretinographics | 1 |
26 | full-time/part-time | 1 |
27 | histo-pathologic | 1 |
28 | htn.hypertension | 1 |
29 | medline/embase/conference | 1 |
30 | nonindustry-funded | 1 |
31 | nonoffice | 1 |
32 | ohione | 1 |
33 | partial=1-29 | 1 |
34 | placebo.fourteen | 1 |
35 | placebo.twenty-seven | 1 |
36 | placebo.two | 1 |
37 | poly-user | 1 |
38 | pregnancies.four | 1 |
39 | proliferate-because | 1 |
40 | psychoproteomics | 1 |
41 | review.seventeen | 1 |
42 | since.four | 1 |
43 | soccer-playing | 1 |
44 | ssi/uti | 1 |
45 | statin/low-dose | 1 |
46 | vaso-proliferative | 1 |
1 | 13,498 | 1 |
2 | 13,502 | 1 |
3 | 147,774 | 1 |
4 | 294,159 | 1 |
5 | 5,503 | 1 |
6 | 5/672 | 1 |
7 | arm-training | 1 |
8 | bioinformatic-driven | 1 |
9 | ckd.eight | 1 |
10 | ckd.three | 1 |
11 | cochrane-style | 2 |
12 | electrifying | 1 |
13 | electroretinographics | 1 |
14 | full-time/part-time | 1 |
15 | gh-deficiency | 2 |
16 | histo-pathologic | 1 |
17 | htn.hypertension | 1 |
18 | iscomatrix™ | 3 |
19 | medline/embase/conference | 1 |
20 | meta-analyses.this | 2 |
21 | molecular-genetic | 5 |
22 | nonindustry-funded | 1 |
23 | nonoffice | 1 |
24 | ohione | 1 |
25 | part-time/full-time | 2 |
26 | partial=1-29 | 1 |
27 | pervious | 3 |
28 | placebo.fourteen | 1 |
29 | placebo.twenty-seven | 1 |
30 | placebo.two | 1 |
31 | poly-user | 1 |
32 | postrehabilitation | 5 |
33 | pregnancies.four | 1 |
34 | previous | 20,890 |
35 | proliferate-because | 1 |
36 | psychoproteomics | 1 |
37 | review.seventeen | 1 |
38 | since.four | 1 |
39 | soccer-playing | 1 |
40 | ssi/uti | 1 |
41 | stage-adapted | 2 |
42 | statin/low-dose | 1 |
43 | stress-trained | 2 |
44 | tj- | 2 |
45 | two-to-five | 2 |
46 | vaso-proliferative | 1 |
1 | tj- | 2 |
2 | 13,502 | 1 |
3 | 5/672 | 1 |
4 | 5,503 | 1 |
5 | 147,774 | 1 |
6 | 13,498 | 1 |
7 | partial=1-29 | 1 |
8 | 294,159 | 1 |
9 | histo-pathologic | 1 |
10 | molecular-genetic | 5 |
11 | nonindustry-funded | 1 |
12 | stress-trained | 2 |
13 | stage-adapted | 2 |
14 | nonoffice | 1 |
15 | medline/embase/conference | 1 |
16 | ckd.three | 1 |
17 | cochrane-style | 2 |
18 | part-time/full-time | 2 |
19 | full-time/part-time | 1 |
20 | ohione | 1 |
21 | statin/low-dose | 1 |
22 | proliferate-because | 1 |
23 | two-to-five | 2 |
24 | vaso-proliferative | 1 |
25 | arm-training | 1 |
26 | soccer-playing | 1 |
27 | electrifying | 1 |
28 | ssi/uti | 1 |
29 | review.seventeen | 1 |
30 | placebo.fourteen | 1 |
31 | placebo.twenty-seven | 1 |
32 | bioinformatic-driven | 1 |
33 | htn.hypertension | 1 |
34 | postrehabilitation | 5 |
35 | placebo.two | 1 |
36 | poly-user | 1 |
37 | since.four | 1 |
38 | pregnancies.four | 1 |
39 | electroretinographics | 1 |
40 | psychoproteomics | 1 |
41 | meta-analyses.this | 2 |
42 | previous | 20,890 |
43 | pervious | 3 |
44 | ckd.eight | 1 |
45 | gh-deficiency | 2 |
46 | iscomatrix™ | 3 |